Last updated on November 2017

A 12 Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group study to Assess the Efficacy, Safety, Tolerability, and Actual use of Bococizumab and an Autoinjector (pre-filled pen) in subjects with Primary Hyperlipidemia or Mixed Dyslipidemia


Brief description of study

A 12 Week, Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group study to Assess the Efficacy, Safety, Tolerability, and Actual use of Bococizumab and an Autoinjector (pre-filled pen) in subjects with Primary Hyperlipidemia or Mixed Dyslipidemia

Detailed Study Description

Clinical study of an investigational drug for subjects with high cholesterol who are on some cholesterol lowering medications. (Statins) The investigational product or placebo will be administered with an auto injector (pre-filled pen).
This study is a 12 week treatment period with up to 9 visits to our office in Stockbridge, GA.

Clinical Study Identifier: TX7267

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Ann Felder

Clinical Research Atlanta
Stockbridge, GA USA
  Connect »